Affiliations: DG RTD, European Commission, Brussels, Belgium.
Abstract: The European Parliament, and the Council Regulation on Medicinal
Products for Paediatric Use, intend to increase children's health in Europe by
promoting research, development and authorisation of medicines for paediatric
use. The main objectives are: to increase the development of medicine for children to ensure that paediatric medicines are subject to high quality
research to ensure that medicines for children are appropriately authorised
for paediatric use to improve information available on the use fo medicines for
children to avoid unnecessary studies in children.